We are live on ! Find out more
SEM

Select Medical
SEM

Delisted

SEM was delisted on the 30th of June, 2026.

Back to rankings

240 hedge funds and large institutions have $2.49B invested in Select Medical in 2022 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 87 increasing their positions, 86 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

290% more call options, than puts

Call options by funds: $3.56M | Put options by funds: $914K

1% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 86

0.57% more ownership

Funds ownership: 76.96% → 77.53% (+0.57%)

3% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 40

1% less funds holding

Funds holding: 243 → 240 (-3)

18% less capital invested

Capital invested by funds: $3.04B → $2.49B (-$546M)

Holders
240
Holders Change
-3
Holders Change %
-1.23%
% of All Funds
3.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
87
Reduced
86
Closed
40
Calls
$3.56M
Puts
$914K
Net Calls
+$2.65M
Net Calls Change
+$2.47M

Top Buyers

Rank Fund Capital Flow
1
LSV Asset Management
LSV Asset Management
Illinois
+$41.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$41.3M
3
CCM
Camber Capital Management
Massachusetts
+$24.5M
4
BlackRock
BlackRock
New York
+$18.7M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$9.18M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$36.3M
2
HRCM
Hood River Capital Management
Florida
-$34.2M
3
Millennium Management
Millennium Management
New York
-$23.1M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$19M
5
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$14.2M

SEM Hedge Fund Activity: Q1 2022 in Review

240 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q1 2022, worth a combined $2.49B — down 18% from $3.04B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of SEM and 39 opened new positions — a net loss of 1 holder — while 86 trimmed existing stakes and 87 added.

The largest buyer was LSV Asset Management, adding an estimated $41.4M. The largest seller was OrbiMed, exiting entirely with an estimated $36.3M sold.

  • 240 institutional investors held Select Medical (SEM) as of Q1 2022, down from 243 in Q4 2021.
  • Funds reported $2.49B of Select Medical stock for Q1 2022, down 18% quarter-over-quarter.
  • 39 funds opened new Select Medical positions in Q1 2022 and 40 closed out, a net change of -1 holder.
  • The largest Select Medical buyer in Q1 2022 was LSV Asset Management, an estimated $41.4M added.
  • The largest Select Medical seller in Q1 2022 was OrbiMed, an estimated $36.3M sold.

Based on aggregated 13F filings for Q1 2022.